Erratum: Time to benefit for colorectal cancer screening: Survival meta-analysis of flexible sigmoidoscopy trials (BMJ (Online) (2015) 350 (h1662) DOI:10.1136/bmj.h1662);Time to benefit for colorectal cancer screening: Survival meta-analysis of flexible sigmoidoscopy trials

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Tang, Victoria ^a   Boscardin, W John ^a,b   Stijacic Cenzer, Irena ^a,b   Lee, Sei J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COCHRANE LIBRARY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLEXIBLE SIGMOIDOSCOPY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OCCULT BLOOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; MONTE CARLO METHOD; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; SURVIVAL;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIGMOIDOSCOPY; SURVIVAL ANALYSIS;

EID: 84929493313     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h2228     Document Type: Erratum

References (30)

1. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
2. Kewenter J, Brevinge H, Engaras B, et al. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68, 308 subjects. Scand J Gastroenterol 1994;29:468-73.
3. Kronborg O, Jorgensen OD, Fenger C, et al. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004;39:846-51.
4. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
5. Scholefeld JH, Moss S, Sufi F, et al. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002;50:840-4.
6. Thiis-Evensen E, Hof GS, Sauar J, et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414-20.
7. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New Engl J Med 1993;329:1977-81.
8. Atkin WS, Hart A, Edwards R, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998;42:560-5.
9. Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal cancer. Dis Colon Rectum 1996;39:676-80.
10. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001;285:2750-6.
11. Qaseem A, Denberg TD, Hopkins RH Jr, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 2012;156:378-86.
12. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
13. Holme O, Loberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 2014;312:606-15.
14. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. New Engl J Med 2012;366:2345-57.
15. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 2011;103:1310-22.
16. Department of Veterans Afairs. Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM). 2012. http://clinicaltrials.gov/show/NCT01239082.
17. Kaminski MF, Bretthauer M, Zauber AG, et al. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012;44:695-702.
18. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. New Engl J Med 2012;366:697-706.
19. UK Department of Health. Improving outcomes: a strategy for cancer. 2011. www.gov. uk/government/uploads/system/uploads/attachment-data/fle/213785/dh-123394.pdf.
20. Cho H, Klabunde CN, Yabrof KR, et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med 2013;159:667-76.
21. Yourman LC, Lee SJ, Schonberg MA, et al. Prognostic indices for older adults: a systematic review. JAMA 2012;307:182-92.
22. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, et al. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 2013;346:e8441.
23. Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013;9: CD009259.
24. Messori A, Trippoli S, Vaiani M, et al. Survival meta-analysis of individual patient data and survival meta-analysis of published (aggregate) data. Clin Drug Investig 2000;20:309-16.
25. Earle CC, Wells GA. An assessment of methods to combine published survival curves. Med Decis Mak 2000;20:104-11.
26. Ouwens MJNM, Philips Z, Jansen JP. Network meta-analysis of parametric survival curves. Res Synth Methods 2011;1:258-71.
27. Whitlock E P, Lin J, Liles E, et al. Screening for colorectal cancer: an updated systematic review. US Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews, 2008.
28. Croswell JM, Kramer BS, Kreimer AR, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med 2009;7:212-22.
29. Lee SJ, Leipzig RM, Walter LC. Incorporating lag time to benefit into prevention decisions for older adults. JAMA 2013;310:2609-10.
30. Gerrish CA. Purposes, values and objectives in adult education-the post-basic perspective. Nurse Educ Today 1990;10:118-24.